NCT07929051
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07929051
Title A Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With Obrixtamig
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Universitair Ziekenhuis Gent Ghent 9000 Belgium Details
INS Bergonie Bordeaux 33000 France Details
Hopital Louis Pradel Bron 69677 France Details
INS Curie Paris 75005 France Details
HOP Civil Strasbourg 67091 France Details
Institut Gustave Roussy Villejuif 94805 France Details
Technische Universität Dresden Dresden 01307 Germany Details
Universitätsklinikum Frankfurt Frankfurt 60590 Germany Details
Universitätsklinikum Würzburg AÖR Würzburg 97078 Germany Details
Saitama Medical University International Medical Center Saitama, Hidaka 350-1298 Japan Details
National Cancer Center Hospital Tokyo, Chuo-ku 104-0045 Japan Details
Medical University Gdansk Gdansk 80-214 Poland Details
Polish Mother's Memorial Hospital - Research Institute Lodz 93338 Poland Details
Hospital Universitario Ramon Y Cajal Madrid 28034 Spain Details
Fundación Jiménez Díaz Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field